Abstract
Reye’s syndrome was a rare disease which appeared suddenly in the early 1950s and disappeared just as suddenly in the late 1980s. An association between Reye’s syndrome and the ingestion of aspirin (acetylsalicylic acid) was claimed, although no proof of causation was ever established. The presence of salicylates in the blood or urine of Reye’s syndrome patients has not been demonstrated, and no animal model of Reye’s syndrome has been developed where aspirin causes the disease. It is clear from epidemiological data that the incidence of Reye’s syndrome was decreasing well before warning labels were placed on aspirin products. Reye’s syndrome disappeared from countries where aspirin was not used in children as well as from countries which continued to use aspirin in children. Reye’s syndrome was probably either a viral mutation which spontaneously disappeared, or a conglomeration of metabolic disorders that had not been recognized or described at that time.
Similar content being viewed by others
References
Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity of childhood. Lancet 1963; II: 749–52
Sullivan-Bolyei JZ, Corey L. Epidemiology of Reye syndrome. Epidemiol Rev 1981; 3: 1–26
Bove KE. The character and specificity of the hepatic lesion in Reye’s syndrome. In: Pollack JD, editor. Reye’s syndrome: Proceedings of the Reye’s Syndrome Conference.; 1974; Columbus (OH). New York: Grune & Statton, 1975: 93–116
Starko KM, Ray CG, Dominguez LB, et al. Reye’s syndrome and salicylate use. Pediatrics 1980; 66(6): 854–64
Waldman RJ, Hall WN, McGee H, et al. Aspirin as a risk factor in Reye’s syndrome. JAMA 1972; 247(22): 3089–94
Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye’s syndrome and medication use. JAMA 1982; 248(6): 687–91
Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study on Reye’s syndrome and medications: report of the pilot phase. N Engl J Med 1985; 313: 849–57
Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study of Reye’s syndrome and medications: report of the main study. JAMA 1987; 257: 1905–11
Food and Drug Administration, Department of Health and Human Services. Labeling for salicylate-containing drug products. Federal Register, 1992 Dec 8, 57892
Yule GU. The function of statistical method in scientific investigation. London: MSO Press, 1924: 2
Casteels-Van Daele M, Van Geet C, Wouters C, et al. Reye syndrome revisited: a descriptive term covering a group of heterogenous disorders. Eur J Pediatr 2000; 159: 641–8
Forysth BW, Horwitz RI, Acampora D, et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye syndrome association. JAMA 1989; 26: 2517–24
Hall SM, Plaster PA, Glasgow JFT, et al. Preadmission antipyretics in Reye’s syndrome. Arch Dis Child 1988; 63: 857–8
Orlowski JP, Gillis J, Kilham HA. A catch in the Reye. Pediatrics 1987; 80: 638–42
Orlowski JP, Campbell P, Goldstein S. Reye’s syndrome: a case control study of medication use and associated viruses in Australia. Cleve Clin J Med 1990; 57: 323–9
Hofman KJ, Rosen EU. Reye’s syndrome in Johannesburg: epidemiology and clinical presentation. S Afr Med J 1982; 61: 281–2
Glasgow JFT. Clinical features and prognosis of Reye’s syndrome. Arch Dis Child 1984; 59: 230–5
Yamashita F, Eiichiro O, Kimura A, et al. Reye’s syndrome in asian countries. In: Pollack JD, editor. Reyes syndrome. 4th edition. Bryon (OH): National Reye’s Syndrome Foundation, 1985: 47–60
Palomeque A, Domench P, Martinez-Gutierrez A, et al. Sindrome de Reye en Espana, 1980-1984 (Estudio cooperativo. Seccion de CIP de la AEP) [in Spanish]. An Esp Pediatr 1986; 24: 285–9
Gladtke E, Schousell-Zipf U. Reye-syndrome. Monatsschr Kinderheilkd 1987; 135: 699–704
Yu ECL. Reye’s syndrome in Hong Kong. Aust Pediatr J 1988; 24: 61
Nicolosi A, Hauser NA, Kurland LT, et al. Reye’s syndrome: incidence and time trends in Olmstead County, MN, 1950- 1981. Neurology 1985; 35: 1338–40
Lichtenstein PK, Heubi JE, Daugherty CC, et al. Grade I Reye’s syndrome: a frequent cause of vomiting and liver dysfunction after varicella and upper respiratory tract infection. N Engl J Med 1983; 309: 133–9
Gauthier M, Guay J, Lortie A, et al. The disappearance of Reye’s syndrome: fact or fancy? Crit Care Med 1988; 16: 375–87
Gauthier M, Guay J, Lacroix J, et al. Reye’s syndrome: a reappraisal of diagnosis in 49 presumptive cases. Am J Dis Child 1989; 143: 1181–5
De Villemeur TB, Nuttin C, Poggi F, et al. Metabolic investigations in Reye’s syndrome and Reye-like syndrome. In: Buts JP, Sokal EM, editors. Management of digestive and liver disorders in infants and children. Amsterdam; Elsevier Publishers, 1993: 615–22
Orlowski JP. What ever happened to Reye’s syndrome: did it ever really exist? Crit Care Med 1999; 27: 1582–7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orlowski, J.P., Hanhan, U.A. & Fiallos, M.R. Is Aspirin a Cause of Reye’s Syndrome?. Drug-Safety 25, 225–231 (2002). https://doi.org/10.2165/00002018-200225040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200225040-00001